<?xml version="1.0" encoding="UTF-8"?>
<ref id="B41-antibiotics-09-00628">
 <label>41.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ricciardi</surname>
    <given-names>M.R.</given-names>
   </name>
   <name>
    <surname>Licchetta</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Mirabilii</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Scarpari</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Parroni</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Fabbri</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Cescutti</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Reverberi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Fanelli</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Tafuri</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Preclinical antileukemia activity of tramesan: a newly identified bioactive fungal metabolite</article-title>
  <source>Oxid. Med. Cell. Longev.</source>
  <year>2017</year>
  <pub-id pub-id-type="doi">10.1155/2017/5061639</pub-id>
 </element-citation>
</ref>
